PISCATAWAY, N.J., July 14, 2008 - Sabinsa Corporation received Generally Recognized As Safe (GRAS) status for its branded ingredient Cococin(TM), coconut water solids, after an intensive review of safety and toxicology data by an independent panel of respected scientists assembled by Soni & Associates, Inc.
This GRAS status allows Cococin to be used as a nutrient in a variety of foods and beverages such as non-alcoholic and alcoholic beverages, frozen dairy, dairy product analogs, milk products, snack foods, imitation dairy products, chewing gum, instant tea and coffee, and soups.
"Achieving GRAS notification within the target timeframe fulfills one more milestone in Sabinsa's development program to better serve our partners in the food industry," stated Muhammed Majeed, Ph.D., Founder and Chairman, Sabinsa Corporation. "By obtaining GRAS status, not only does the assessment demonstrate the safety of our product, but it also opens other doors for our company."
Cococin, patented in USA and Europe for its use, is a standardized composition of freeze-dried coconut water solids obtained from tender green (immature) coconut fruit. When added as a nutrient to specific foods, Cococin can be beneficial for individuals who wish to increase their daily intake nutrients including potassium and magnesium. Long considered a refreshing beverage and even a natural sports drink in Southeast Asia, Central America and other tropical regions, green coconut water has long been valued for its regenerative benefits.
Sabinsa Corporation is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Celebrating its 20th year servicing the natural products industry, Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and wellbeing. Over the past several years, the company has brought to market more than 50 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. Sabinsa has six state-of-the-art manufacturing facilities in India dedicated to the production of herbal extracts, phytochemicals, biotech ingredients and supercritical extracts. In the U.S., the company operates a 42,000-square-foot facility in Payson, Utah, which provides cutting-edge capabilities for the development of capsules, tablets, bulk custom pre-mixes, drum-to-hopper blends, stick packs and powdered drinks. All of Sabinsa's facilities use effluent water treatment systems and are environmentally conscious and friendly. All products are intended for human consumption and certified Kosher. For more information visit www.sabinsa.com.
# # #